CTSS和CD53:新兴的m6A甲基化标志物在糖尿病病的发病过程中及其临床影响
Meng Leilei1, Huang Bin2, Li Rui3
1Department of Pathophysiology, Anhui Medical University, Hefei, 230000, China.
BMC nephrology
|July 7, 2025
概括
这项研究确定了糖尿病病 (DKD) 中的两种N6-甲基氨酸 (m6A) RNA修饰模式,其中一种与增加的免疫细胞透有关. CTSS和CD53显示出作为DKD临床生物标志物的潜力.
科学领域:
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
- 基因组学就是基因组学.
背景情况:
- 糖尿病病 (DKD) 是慢性病 (CKD) 的全球主要原因之一.
- 在DKD病变发生过程中,N6-甲基氨酸 (m6A) RNA修饰的作用尚不清楚.
研究的目的:
- 研究DKD中的m6ARNA修饰模式.
- 探索m6A模式与DKD中的免疫调节之间的关系.
主要方法:
- 分析了三个GEO数据集的m6A修饰模式.
- 利用随机森林建模和共识聚类来识别亚型.
- 通过ssGSEA评估免疫细胞透,并在小鼠模型中验证了关键基因.
主要成果:
- 在DKD中鉴定了八个差异表达的m6A调节器.
- 建立了两种不同的m6A修饰模式,一种是增强免疫细胞透.
- 验证了CTSS和CD53作为潜在的生物标志物,与淋巴膜过率负相关.
结论:
- 在DKD中揭示了两个m6A甲基化模式,一个与增加的免疫透有关.
- 确定了CTSS和CD53作为枢纽基因,有可能成为DKD的临床生物标志物.
相关概念视频
Chronic Kidney Disease I: Introduction
76
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
76
Chronic Kidney Disease II: Clinical Manifestations
104
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
104
Chronic Kidney Disease III: Interprofessional Care
82
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
82


